Company Filing History:
Years Active: 2019
Title: Hanno Langen: Innovator in Chronic Kidney Disease Biomarkers
Introduction
Hanno Langen is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of chronic kidney disease (CKD) through his innovative research and patents. His work focuses on identifying biomarkers that can predict the progression of CKD, which is crucial for improving patient outcomes.
Latest Patents
Hanno Langen holds a patent for "Biomarkers and methods for progression prediction for chronic kidney disease." This invention involves the detection of levels of various biomarkers, including NTpro BNP, EGF, Apo H, GDF-15, and the albumin-to-creatinine ratio. These biomarkers are essential for assessing the risk of CKD progression and for monitoring the effectiveness of therapeutic interventions.
Career Highlights
Throughout his career, Hanno Langen has worked with prestigious institutions, including the University of Michigan and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in kidney disease.
Collaborations
Hanno has collaborated with notable colleagues, including Maria Bobadilla and Laura Badi. Their combined expertise has further advanced the understanding of chronic kidney disease and the development of effective monitoring methods.
Conclusion
Hanno Langen's innovative work in the field of chronic kidney disease biomarkers highlights the importance of early detection and monitoring in improving patient care. His contributions continue to influence research and clinical practices in nephrology.